Furthering the Advancement and Impact
of Medical Device
MedExecWomen 2020 has been postponed to April 6, 2021 in Boston, MA.
This meeting is so important to us all.
Hosting the MedExecWomen meeting in a post-COVID-19 world will require major adjusting — especially for a meeting like ours where content and networking are strategic imperatives.
We don’t know what the post-COVID world will look like for the remainder of 2020 but all hope that 2021 brings us new technologies (vaccines, verified diagnostics, etc.) that allow us to reconvene, together.
Who We Are. What We Do.
MedExecWomen is an organization focused on empowering female executives to accelerate the positive impact of medical devices, diagnostics, drug delivery, and digital healthcare around the world. We’re committed to:
- Creating a network of executive women in medtech and facilitating connections.
- Improving gender parity in medtech leadership positions.
- Educating executives about the benefits of diverse leadership teams and how to optimize talent.
- Supporting the development of leadership skills through training and advancement programs.
Our second annual MedExecWomen Conference will be held on April 6, 2021, hosted by KPMG in Boston, Two Financial Center, 60 South St., Boston, MA 02111.
The second annual MedExecWomen conference will be held on April 6, 2021 in Boston. A one-day event, MedExecWomen will again feature industry executives discussing dynamic topics to provide insight that empowers women and accelerates progress. Panel discussion topics include:
- Assessing Cultural Fit as a Component of M&A: A critical factor in successful integration
- At the Cutting Edge of Digital Health
- Global Development Strategies
- Back by Popular Demand - How to Become a Board Member
Thanks to Our Sponsors
Meeting Theme: Medical Innovation in a Global Economy
Postponed until April 6, 2021
7:00 – 8:00 AM Breakfast
8:00 – 8:30 AM Welcome & Introduction to MedExecWomen
8:30 – 9:15 AM A Patient’s Story: Katherine Leon – SCAD Alliance
Katherine is a survivor of a heart attack caused by spontaneous coronary artery dissection, or SCAD. In 2003, Katherine survived SCAD, heart attack, and double bypass surgery. Finding no single-center, long-term research had ever been conducted on SCAD, she began to pursue this goal herself. After several years participating on the WomenHeart online community, she compiled and presented anecdotal data on SCAD to a researcher at Mayo Clinic. A successful pilot study led to two research initiatives, which began in September 2011; a virtual registry of SCAD patients worldwide and a DNA biobank that includes survivors and relatives.
9:15 – 10:15 AM Panel 1: Global Development Strategies
Regional panelists representing different regions (EU, AP, AUS, US) discuss the constant changes when operating in a global environment. From supply chain to commercialization, regulatory to marketing, you are accountable for maximizing your company’s profits and ensuring success. During this session, listen to experts managing in the worldwide medical device community.
Moderator: Kristin Pothier – Global Healthcare and Life Sciences Strategy Leader, KPMG
- Roz Burke – SVP, Global Quality and Regulatory, Boston Scientific
- Katrin Leadley, MD – Chief Medical Officer, Endotronix
- Corinne Noyes – SVP of Commercial Strategy and Market Development, Lyra
- Heather Knight – General Manager/President, Baxter International)
- Bronwyn Brophy – President EMEA, Thermo Fisher Scientific
10:15 – 10:45 AM Break
10:45 – 11:45 AM Panel 2: Assessing Cultural Fit as a Component of M&A: A Critical Factor in Successful Integration
Assessing cultural fit prior to M&A activity can appear to be a nice-to-have appraisal compared to the financial valuation. Hear from those leading assessments and executing integrations how cultural fit or cultural misalignment can impact the likelihood of delivering deal model expectations.
Moderator: Leslie Storms – Vice President US Sales, Ethicon, a J&J Medical Device Company
- Anita Jensen, Ph.D., M.A., MSW – SVP, Organizational Development & Learning, Jefferson Health & Jefferson University
- Jennifer O’Krancy – Principal, Ernst & Young, People Advisory Services
- Lisa Blair Davis – Head of Global Human Resources, J&J Medical Device Companies
- Gwen Watanabe – Vice President of Global Corporate Development, Strategy and Strategic Relationships, Teleflex
11:45 AM – 12:45 PM Lunch
12:45 – 1:30 PM Executive Interview: Cathy Burzik
Interviewer: Mary Beth Moynihan – SVP, Corporate Marketing and Market Access at Boston Scientific
1:30 – 2:30 Panel 3: State of the Market in Life Sciences
Current views of political, equity capital markets and M&A trends, including how the election may impact 2020; will the IPO bull market continue? Will M&A continue to be filled by smaller deals or will the mega-deal return?
Moderator: Meghna Eichelberger – Associate Director, Medical Technologies, Boston Consulting Group
- Marina Bozilenko – Head of Biotechnology & Pharma, William Blair & Company, LLC
- Kristen M. Stewart – CFA, Medical Supplies & Devices Analyst, Barclays
- Kalli Dircks – Executive Director, Global Capital Markets, Morgan Stanley
- June Lee, Director, Bank of America
2:30 – 3:00 PM Break
3:00 – 3:45 PM Panel 4: At the Cutting Edge of Digital Health
Moderator: Maria Shepherd – CEO, Medi-Vantage
- Luba Greenwood – former Strategic BD & Corp Ventures, Google
- Jodi Eddy – CIO, Boston Scientific
- Anjana Harve – CIO, Hill-Rom
- Vizma Carver – Digital Health Advisor, FDA
3:45-4:30 PM Panel 5: Back by Popular Demand – How to Become a Board Member
Moderator: Rita Allen – President of Boston Club
- Ellen Zane – CEO Emeritus, Tufts Medical Center, Adjunct Assistant Professor of Health Policy and Management, Harvard T.H. Chan School of Public Health
- Teresa Matkovits, Ph.D. – Chief Development Officer, Matinas Biopharma
- Alison Taunton-Rigby – Independent Director, CEO, and Entrepreneur in life science and healthcare organizations
4:30 – 5:00 End of Day Keynote: Globalization in Underdeveloped Countries & Why I Moved to the Gates Foundation
Speaker: Mary Thistle – The Bill & Melinda Gates Medical Research Institute
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis and diarrheal diseases, and to improve outcomes in maternal and newborn health — major causes of mortality, poverty, and inequality in Low- and Middle-Income Countries (LMIC). The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people.